Results 51 - 75 from 145 for "antibiotice"
-
Antibiotice Iasi Shareholders Approve RON2.22M Dividends From 2020 Profit, At 0.6% Yield
04.21.2021
Shareholders of state-run Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Wednesday approved the distribution of dividends worth RON2.2 million from the 2020 profit, more
-
Antibiotice Iasi Expects 7.5% Growth in Revenue to RON366M in 2021
04.15.2021
Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, has budgeted RON366.5 million revenue for 2021, an increase of 7.5% on 2020, as shown in its spending and revenue budget. more
-
SIF Oltenia Reaches 23% Ownership In Antibiotice Iasi
04.14.2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, said in a stock market report on Wednesday that regional investment fund SIF Oltenia (SIF5.RO) reached more
-
Antibiotice Iasi Investments Double YoY To RON14M In 2020
03.24.2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has invested RON14 million in new product research and equipment in 2020, double compared with 2019, per more
-
Antibiotice Iasi Seeks to Distribute RON2.2M as Dividends
03.18.2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, plans to distribute RON2.2 million as dividends from its 2020 profit of RON26 million profit. more
-
Antibiotice Iasi Net Profit Drops 16% in 2002, to RON25M
02.25.2021
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, on Thursday reported a 16% drop in net profit in 2002, to RON25 million. more
-
Antibiotice Iasi To Provide Antibiotic Used in Covid Treatment to EU
10.16.2020
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has won a tender held by the European Commission to supply necessary stock for the second wave of the Covid pandemic. more
-
Antibiotice Iasi Enters US and UK Markets with Covid-19 Medication
07.09.2020
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has entered the US and UK markets with new medicines for Covid-19 by attending and winning tenders in the US and UK. more
-
Antibiotice Iasi Extends CEO's Mandate For Four Years
05.20.2020
-
Antibiotice Iasi Approves RON20M Dividends: 5.6% Yield
04.09.2020
-
Antibiotice Iasi Sales Up Driven By 30% Higher Demand Compared With Previous Months
03.30.2020
Antibiotice Iasi, the largest pharmaceutical producer in Romania, has seen sales up lately, as demand for medicines increased 30%, company CEO Ioan Nani says. more
-
Antibiotice Iasi Net Profit Declines 10% in 2019, to RON30.8M
02.27.2020
State-owned Antibiotice Iasi (ATB.RO), one of the leading local pharmaceutical manufacturers, said Thursday its net profit declined 10% in 2019, to RON30.8 million, while sales revenue grew 6.8%, to more
-
Antibiotice Iasi Plans to Double Exports and Revenue Starting 2020
12.18.2019
Antibiotice Iasi (ATB.RO), one of the leading local pharmaceutical manufacturers, plans to double exports abroad soon, which would double its revenue. more
-
Antibiotice Iasi Posts RON242M Sales, RON21.5M Net Profit In Jan-Sept 2019
11.15.2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Friday said it ended the first nine months of 2019 with sales revenue of RON242 million, comparable with the result reported more
-
Antibiotice Iasi Plans To Register Over 25 Products In Vietnam
10.08.2019
Antibiotice Iasi, one of the leading players in the local pharmaceuticals industry and the main producer of the active substance nystatin globally, plans to register in Vietnam over 25 products in more
-
Antibiotice CEO Ioan Nani Plans to Double Salaries at His Company in Five Years
09.24.2019
The ambition of Ioan Nani, CEO of pharmaceutical producer Antibiotice Iasi and one of the longest-standing executives in local pharmaceutical industry is too boost sales and profitability over the more
-
Antibiotice Iasi To Start Payment Of RON6.7M Dividends As Of Sept 20
09.06.2019
-
Antibiotice Iasi Posts Higher Sales, Profit in 1H/2019
08.08.2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Thursday reported total sales of RON172.3 million in the first half of the year, up 9%, and a net profit of RON22.3 million, more
-
Antibiotice Iasi to Double Production of Creams and Ointments by 2020
11.28.2018
Pharmaceutical producer Antibiotice Iasi’s investment in its new topical product (such as creams, lotions and ointments) plant will amount to EUR20 million and will be completed by the end of next more
-
Antibiotice Iasi 9-Month Sales Up 3% On Year To RON241M
11.14.2018
-
Antibiotice Iasi To Pay Out RON17.8M Worth Of Dividends, At 5% Yield
04.26.2018
-
Antibiotice To Open Offices In Kiev And Chisinau
02.26.2018
Pharmaceutical company Antibiotice (ATB.RO) reached its targets last year and will continue development by consolidating presence on international markets this year, says CEO Ioan Nani. more
-
Antibiotice Iasi Sales Revenue Up 3%, Net Profit Up 14% In First 9 Months Of 2017
11.15.2017
-
Antibiotice Iasi GM: Romania Has Europe's Lowest Drug Prices And World's Highest Clawback Tax
09.13.2017
-
Antibiotice Iasi Posts Higher Profit, Of RON19.19M, In 1H/2017
08.17.2017